Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EndoTic – Endothelium and Ticagrelor in ACS
2013-005042-11Phase 4Completed
- Sponsor
- Fundación de Investigación Sanitaria de León
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ticagrelor in acute coronary syndrome (ACS) (2 arms), sponsored by Fundación de Investigación Sanitaria de León. Primary endpoint: Change in circulating endothelial cells (CECs) and endothelial progenitor cells (EPCs). Started Feb 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2013-005042-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005042-11.